Company Overview Galectin Therapeutics develops therapies targeting galectin proteins, focusing on its lead drug, belapectin, for MASH cirrhosis. Key Financial…
Company Overview Kodiak Sciences is a precommercial biotechnology company focused on researching, developing, and commercializing transformative therapeutics for retinal diseases.…
BIO-key International delivered a narrower quarterly loss but revenue deterioration accelerated, raising questions about near-term growth visibility despite ...